Bio-Key International Inc Files Prospectus Relates To Resale, From Time To Time, By Selling Stockholder Of Up To 900,000 Shares Of Common Stock
Portfolio Pulse from Benzinga Newsdesk
Bio-Key International Inc has filed a prospectus related to the resale of up to 900,000 shares of common stock by a selling stockholder, according to an SEC filing.
June 15, 2023 | 8:27 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Bio-Key International's filing of a prospectus for the resale of up to 900,000 shares of common stock by a selling stockholder may impact its stock price.
The filing of a prospectus for the resale of shares by a selling stockholder indicates that there may be an increase in the supply of BKYI shares in the market. This could potentially put downward pressure on the stock price. However, the impact on the stock price will depend on the demand for the shares and the overall market sentiment.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100